Relationship between different forms of dietary choline and ovarian cancer survival: findings from the ovarian cancer follow-up study, a prospective cohort study.

Background: Choline has important and diverse functions in both cellular maintenance and growth. However, the relationships between the prediagnosis of the different forms of dietary choline intake and ovarian cancer (OC) survival are relatively unknown. This study is the first to investigate this topic based on the Ovarian Cancer Follow-Up Study, a prospective cohort study conducted in China. Methods: In the present study, 635 new cases of ovarian cancer between the ages of 18 and 79 were enrolled. A valid and reliable 111-item food frequency questionnaire was used to assess dietary choline intake. Deaths were ascertained until March 31, 2021, via medical records and active follow-up. Multivariable-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: During a median follow-up of 37.2 months (interquartile: 24.7-50.2 months), 114 deaths were identified. Higher lipid-soluble choline intake was significantly associated with better overall survival for patients with OC (Tertile 3 vs. Tertile 1: HR = 0.56; 95% CI: 0.34, 0.92; P trend = 0.02) in the fully adjusted model. Similar associations were observed for phosphatidylcholine intake (Tertile 3 vs. Tertile 1: HR = 0.55; 95% CI: 0.33, 0.91; P trend = 0.02). However, no associations were found between total water-soluble choline (free choline, phosphocholine, and glycerophosphocholine), sphingomyelin, and betaine intake and OC survival. Significant additive interactions between higher fat-soluble choline intake and positive expression of estrogen receptor and Wilms tumor-1 as well as higher phosphatidylcholine intake and positive expression of estrogen receptor and Wilms tumor-1 on OC survival were detected. Conclusions: Our findings indicate that prediagnosis, total lipid-soluble choline and phosphatidylcholine intake were associated with improved overall survival among OC patients.

[1]  Yashu Liu,et al.  A Follow-Up Study of Ovarian Cancer (OOPS): A Study Protocol , 2022, Frontiers in Nutrition.

[2]  Qijun Wu,et al.  Pre-diagnostic dietary consumption of calcium and magnesium and calcium-to-magnesium intake ratio and ovarian cancer mortality: results from the ovarian cancer follow-up study (OOPS) , 2022, European Journal of Nutrition.

[3]  J. Blumberg,et al.  Dietary Supplements for Weight Management: A Narrative Review of Safety and Metabolic Health Benefits , 2022, Nutrients.

[4]  Qijun Wu,et al.  Pre-diagnosis Dietary One-Carbon Metabolism Micronutrients Consumption and Ovarian Cancer Survival: A Prospective Cohort Study , 2022, Frontiers in Nutrition.

[5]  Stacey A. Kenfield,et al.  American Cancer Society nutrition and physical activity guideline for cancer survivors , 2022, CA: a cancer journal for clinicians.

[6]  Li Dong Wang,et al.  Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma , 2022, Frontiers in Oncology.

[7]  Yuhong Zhao,et al.  Association between pre-diagnostic dietary pattern and survival of ovarian cancer: evidence from a prospective cohort study with 853 ovarian cancer patients , 2021, Clinical Nutrition.

[8]  Yuhong Zhao,et al.  Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study , 2021, Frontiers in Nutrition.

[9]  H. Rui,et al.  RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site , 2021, Cell reports.

[10]  P. Ueland,et al.  Assessment of Dietary Choline Intake, Contributing Food Items, and Associations with One-Carbon and Lipid Metabolites in Middle-Aged and Elderly Adults: The Hordaland Health Study , 2021, The Journal of nutrition.

[11]  Nary Tao,et al.  Association Between Dietary Intake of One-Carbon Metabolism-Related Nutrients and Fluorosis in Guizhou, China , 2021, Frontiers in Nutrition.

[12]  A. Di Spiezio Sardo,et al.  Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study. , 2021, Gynecologic oncology.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  M. Gueimonde,et al.  The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases , 2020, Nutrients.

[15]  R. Bekdash.  Neuroprotective Effects of Choline and Other Methyl Donors , 2019, Nutrients.

[16]  M. van der Aa,et al.  Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer. , 2019, Gynecologic oncology.

[17]  Zuo-Feng Zhang,et al.  Raw Garlic Consumption and Risk of Liver Cancer: A Population-Based Case-Control Study in Eastern China , 2019, Nutrients.

[18]  A. Imhof,et al.  The Impact of One Carbon Metabolism on Histone Methylation , 2019, Front. Genet..

[19]  D. Sarkar,et al.  Persistent changes in stress-regulatory genes in pregnant woman or a child with prenatal alcohol exposure. , 2019, Alcoholism, clinical and experimental research.

[20]  Mohamed M. Ali,et al.  Methyl Donor Micronutrients that Modify DNA Methylation and Cancer Outcome , 2019, Nutrients.

[21]  E. Platz,et al.  Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study , 2019, Cancer Causes & Control.

[22]  K. Hua,et al.  Comparison and analysis of the clinicopathological features of SCEO and ECOM , 2019, Journal of Ovarian Research.

[23]  A. Ayhan,et al.  Comparison of stage III mucinous and serous ovarian cancer: a case-control study , 2018, Journal of Ovarian Research.

[24]  S. Barr,et al.  Dietary Choline Intake: Current State of Knowledge Across the Life Cycle , 2018, Nutrients.

[25]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[26]  A. Saxena,et al.  Maternal betaine supplementation affects fetal growth and lipid metabolism of high-fat fed mice in a temporal-specific manner , 2018, Nutrition & Diabetes.

[27]  Long-Bang Chen,et al.  Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma , 2017, Journal of experimental & clinical cancer research : CR.

[28]  H. Fan,et al.  TET1 inhibits cell proliferation by inducing RASSF5 expression , 2017, Oncotarget.

[29]  E. Bandera,et al.  Impact of body mass index on ovarian cancer survival varies by stage , 2017, British Journal of Cancer.

[30]  Y. Shu,et al.  Choline and betaine consumption lowers cancer risk: a meta-analysis of epidemiologic studies , 2016, Scientific Reports.

[31]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[32]  S. Hauptmann,et al.  The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications , 2016, Archives of Gynecology and Obstetrics.

[33]  E. Lewis,et al.  Should the forms of dietary choline also be considered when estimating dietary intake and the implications for health , 2015 .

[34]  F. Davis,et al.  The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois. , 2015, Annals of epidemiology.

[35]  Z. Pan,et al.  Choline and Betaine Intake and Colorectal Cancer Risk in Chinese Population: A Case-Control Study , 2015, PloS one.

[36]  H. Hollema,et al.  Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer , 2014, Oncoimmunology.

[37]  Jae Kwan Lee,et al.  The Effect of Body Mass Index on Survival in Advanced Epithelial Ovarian Cancer , 2014, Journal of Korean medical science.

[38]  G. Anderson,et al.  Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative. , 2014, Gynecologic oncology.

[39]  A. deFazio,et al.  Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival. , 2014, Gynecologic oncology.

[40]  Y-k Lu,et al.  Choline and betaine intakes are associated with reduced risk of nasopharyngeal carcinoma in adults: a case–control study , 2013, British Journal of Cancer.

[41]  S. Ho,et al.  Choline and betaine intake is inversely associated with breast cancer risk: A two‐stage case‐control study in China , 2013, Cancer science.

[42]  Z. Bhujwalla,et al.  Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.

[43]  A. Neugut,et al.  High intakes of choline and betaine reduce breast cancer mortality in a population‐based study , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  S. Zeisel,et al.  Choline: an essential nutrient for public health. , 2009, Nutrition reviews.

[45]  Robert C. Bast,et al.  The biology of ovarian cancer: new opportunities for translation , 2009, Nature Reviews Cancer.

[46]  D. Panagiotakos,et al.  Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. , 2008, The American journal of clinical nutrition.

[47]  S. Zeisel.  Choline: critical role during fetal development and dietary requirements in adults. , 2006, Annual review of nutrition.

[48]  Meir J. Stampfer,et al.  Total energy intake: implications for epidemiologic analyses. , 1986, American journal of epidemiology.

[49]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.